130 related articles for article (PubMed ID: 3870538)
1. [Determination of estrogen and progesterone receptors in cancer of the breast. Frequency of presentation and prognostic significance].
Expósito J; Olea N; Ruiz de Almodovar JM; Pedraza V
Rev Esp Oncol; 1985; 32(3):471-85. PubMed ID: 3870538
[TBL] [Abstract][Full Text] [Related]
2. [Hormonreceptors in the therapy concept of breast cancer (author's transl)].
Jonat W; Maass H
Arch Geschwulstforsch; 1981; 51(7):637-41. PubMed ID: 7337546
[TBL] [Abstract][Full Text] [Related]
3. [Experimental and clinical experiences with steroid hormone receptors in breast cancer].
Jonat W
Wien Klin Wochenschr; 1984 Jun; 96(13):499-508. PubMed ID: 6089443
[TBL] [Abstract][Full Text] [Related]
4. Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers.
Liu H; Fan Q; Zhang Z; Li X; Yu H; Meng F
Hum Pathol; 2008 Feb; 39(2):167-74. PubMed ID: 18045647
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.
Fitzpatrick SL; Brightwell J; Wittliff JL; Barrows GH; Schultz GS
Cancer Res; 1984 Aug; 44(8):3448-53. PubMed ID: 6331648
[TBL] [Abstract][Full Text] [Related]
6. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.
Rakha EA; El-Sayed ME; Green AR; Paish EC; Powe DG; Gee J; Nicholson RI; Lee AH; Robertson JF; Ellis IO
J Clin Oncol; 2007 Oct; 25(30):4772-8. PubMed ID: 17876012
[TBL] [Abstract][Full Text] [Related]
7. [The importance of hormone receptor determination in breast malignancies].
Nikolić D; Branković M; Polić Dj; Spuzić I
Glas Srp Akad Nauka Med; 1991; (41):121-30. PubMed ID: 1916439
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of estrogen receptor status as assessed by ligand-binding assay in patients with early-stage breast cancer treated with breast conserving surgery and radiation therapy.
Takei H; Horiguchi J; Maemura M; Koibuchi Y; Oyama T; Yokoe T; Iino Y; Morishita Y
Oncol Rep; 2002; 9(2):375-8. PubMed ID: 11836611
[TBL] [Abstract][Full Text] [Related]
9. Relationship of cytoplasmic and nuclear estrogen receptors and progesterone receptors in human breast cancer.
Romić-Stojković R; Gamulin S
Cancer Res; 1980 Dec; 40(12):4821-5. PubMed ID: 7438115
[TBL] [Abstract][Full Text] [Related]
10. Menopausal hormone therapy and breast cancer phenotype: does dose matter?
Garwood ER; Kumar AS; Shim V
Ann Surg Oncol; 2008 Sep; 15(9):2526-32. PubMed ID: 18618187
[TBL] [Abstract][Full Text] [Related]
11. Estrogen and progesterone receptors status in Thai female breast cancer patients: an analysis of 399 cases at King Chulalongkorn Memorial Hospital.
Lertsanguansinchai P; Chottetanaprasith T; Chatamra K; Sampatanukul P; Wannakrairot P; Rojpornpradit P; Shotelersuk K; Lertbutsayanukul C; Boonjunwetwat D; Vajragupta L
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S193-202. PubMed ID: 12188412
[TBL] [Abstract][Full Text] [Related]
12. Problems and solutions in the evaluation of hormone receptors in breast cancer.
Allred DC
J Clin Oncol; 2008 May; 26(15):2433-5. PubMed ID: 18487563
[No Abstract] [Full Text] [Related]
13. Is triple negative a prognostic factor in breast cancer?
Nishimura R; Arima N
Breast Cancer; 2008; 15(4):303-8. PubMed ID: 18369692
[TBL] [Abstract][Full Text] [Related]
14. Long-term survival in primary breast cancer: correlation with estrogen and progesterone receptor assay results and adjuvant tamoxifen therapy.
Chrapusta SJ; Giermek J; Pieńkowski T
Med Sci Monit; 2004 Oct; 10(10):CR577-86. PubMed ID: 15448598
[TBL] [Abstract][Full Text] [Related]
15. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
Pujol P; Daures JP; Thezenas S; Guilleux F; Rouanet P; Grenier J
Cancer; 1998 Aug; 83(4):698-705. PubMed ID: 9708933
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen value as a marker in breast cancer.
Narita D; Cimpean AM; Anghel A; Raica M
Neoplasma; 2006; 53(2):161-7. PubMed ID: 16575473
[TBL] [Abstract][Full Text] [Related]
17. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic and nuclear estrogen and progesterone receptors in male breast cancer.
Pegoraro RJ; Nirmul D; Joubert SM
Cancer Res; 1982 Nov; 42(11):4812-4. PubMed ID: 7127316
[TBL] [Abstract][Full Text] [Related]
19. [Estradiol and progesterone receptors in loco-regional breast cancer. Clinical and prognostic correlations].
Bolla M; Chedin M; Chambaz E; Gabelle P
Sem Hop; 1984 Jan; 60(2):91-6. PubMed ID: 6322331
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer.
Yamashita H; Nishio M; Kobayashi S; Ando Y; Sugiura H; Zhang Z; Hamaguchi M; Mita K; Fujii Y; Iwase H
Breast Cancer Res; 2005; 7(5):R753-64. PubMed ID: 16168121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
